Journal of Pharmaceutical Policy and Practice最新文献

筛选
英文 中文
Adverse drug reaction reporting by community pharmacists: attitudes, practices, barriers, and facilitators. 社区药剂师的药物不良反应报告:态度、做法、障碍和促进因素。
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-11-09 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2749254
Anan S Jarab, Walid Al-Qerem, Karem H Alzoubi, Shrouq R Abu Heshmeh, Hala Kharoub, Osama H Abusara, Yazid N Al Hamarneh, Eman Alefishat
{"title":"Adverse drug reaction reporting by community pharmacists: attitudes, practices, barriers, and facilitators.","authors":"Anan S Jarab, Walid Al-Qerem, Karem H Alzoubi, Shrouq R Abu Heshmeh, Hala Kharoub, Osama H Abusara, Yazid N Al Hamarneh, Eman Alefishat","doi":"10.1080/20523211.2026.2749254","DOIUrl":"https://doi.org/10.1080/20523211.2026.2749254","url":null,"abstract":"<p><strong>Background: </strong>Adverse drug reactions (ADRs) pose a significant threat to public health, increasing morbidity and mortality rates globally. In the UAE, a national pharmacovigilance programme established by the Ministry of Health and Prevention encourages healthcare professionals, including community pharmacists, to report ADRs, although reporting is currently voluntary rather than mandatory. Timely and accurate ADR reporting is essential to enhance patient safety, minimise negative effects, and improve overall healthcare outcomes. <i>Therefore</i>, <i>we aimed to</i> evaluate community pharmacists' attitudes and practices regarding ADR reporting and to explore the associated barriers and facilitators to provide this service.</p><p><strong>Methods: </strong>In this cross-sectional study, a validated questionnaire was distributed online to community pharmacists across the UAE via social media platforms, such as Facebook, WhatsApp, and X. The study utilised a custom-designed questionnaire to assess community pharmacists' attitude, practice, barriers, and facilitators regarding ADR reporting.</p><p><strong>Results: </strong>A total of 533 pharmacists participated in this study. The median age was 35 years (30-42). The participants had an overall good attitude, but inadequate practice regarding ADR reporting. Lack of time (49%), poor communication with the patient (49%), reporting ADRs of multiple medications (37%), and lack of confidence to discuss ADRs with the prescriber (37%) were the most identified barriers to ADR reporting, while reminders (54%) and empowering patients (53%) were the most commonly suggested facilitators. Female pharmacists had significantly higher attitude than male pharmacists, while pharmacists who had B pharm showed less practice than those holding a post-graduate degree.</p><p><strong>Conclusion: </strong>Pharmacists should engage in awareness and education campaigns aimed at enhancing their communication skills and increasing their confidence and abilities in reporting ADRs, with a specific emphasis on male and less educated pharmacists. Additionally, the integration of reminders and initiatives that empower patients can help overcome barriers to ADR reporting. These efforts have the potential to enhance medication management and boost patient safety.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2749254"},"PeriodicalIF":2.6,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13757797/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring over-the-counter SABA inhaler use in Malaysian community pharmacies: a mixed-methods study. 探索非处方SABA吸入器在马来西亚社区药房的使用:一项混合方法研究。
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-11-06 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2750478
Rabia Hussain, Zhe Chi Loh, Bayan Faisal Ababneh, Siew Chin Ong, Jaya Muneswarao
{"title":"Exploring over-the-counter SABA inhaler use in Malaysian community pharmacies: a mixed-methods study.","authors":"Rabia Hussain, Zhe Chi Loh, Bayan Faisal Ababneh, Siew Chin Ong, Jaya Muneswarao","doi":"10.1080/20523211.2026.2750478","DOIUrl":"https://doi.org/10.1080/20523211.2026.2750478","url":null,"abstract":"<p><strong>Background: </strong>Non-prescription short-acting beta-2 agonists (SABA) inhalers, used to relieve asthma symptoms, are widely available in community pharmacies. This study aimed to explore the perceptions and practices of community pharmacists towards the safe use of SABA inhalers in Malaysia.</p><p><strong>Methods: </strong>A concurrent mixed-methods study was conducted from December 2022 to May 2023, involving qualitative interviews (n = 12) and quantitative online surveys (n = 312) among Malaysian community pharmacists. Qualitative data was managed through NVivo® software, and thematic analysis was performed. Descriptive data analysis, including Kruskal-Wallis and Mann-Whitney tests, and regression analysis were performed using IBM SPSS v.20 for the quantitative study. Subsequently, a comparison was made between the qualitative and quantitative data.</p><p><strong>Results: </strong>Most community pharmacists commonly linked effective asthma control with fewer exacerbations (n = 12) (84.3%), and decreased usage of SABA inhalers (n = 12) (65.4%), in the qualitative and quantitative studies, respectively. According to the quantitative results, 40.7% of participants were concerned with the frequency and dosage of SABA usage by asthma patients OTC. While in the qualitative phase, community pharmacists (n = 12) emphasised proper inhalation techniques for safe and effective use of non-prescription SABA inhalers. Community pharmacists from both studies suggested that effective counselling, including allocating sufficient time for counselling sessions, could enhance the safe use of SABA inhalers. The most agreed-upon perceived barriers to safe SABA inhaler use in the quantitative results were patients' lack of awareness of available services for asthma consultations and counselling (74.4%) and insufficient time to provide counselling services (68.9%).</p><p><strong>Conclusion: </strong>Community pharmacists in Malaysia correlated good asthma control status with decreased exacerbations and SABA inhaler utilisation. Furthermore, community pharmacists were concerned about patients' techniques, dosage, and frequency of use of SABA inhalers. However, asthma reviews, monitoring systems, and patient counselling were important suggested factors in ensuring safe and effective treatment in the community pharmacy setting.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2750478"},"PeriodicalIF":2.6,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13757800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community pharmacists' knowledge, attitudes, and educational needs regarding LGBTQ+ healthcare: a cross-sectional study. 社区药剂师对LGBTQ+医疗保健的知识、态度和教育需求:一项横断面研究
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-11-04 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2753953
Michael Petrides, Ilias Tanis, Vasileios Kiosses, Aliki Peletidi
{"title":"Community pharmacists' knowledge, attitudes, and educational needs regarding LGBTQ+ healthcare: a cross-sectional study.","authors":"Michael Petrides, Ilias Tanis, Vasileios Kiosses, Aliki Peletidi","doi":"10.1080/20523211.2026.2753953","DOIUrl":"https://doi.org/10.1080/20523211.2026.2753953","url":null,"abstract":"<p><strong>Background: </strong>LGBTQ+ individuals continue to experience persistent healthcare inequalities, partly due to limited training of healthcare professionals in LGBTQ+-specific healthcare needs. Community pharmacists (CPs), given their accessibility and role in frontline healthcare delivery, are well-positioned to provide inclusive and competent care. This study aimed to describe participating CPs' self-reported knowledge and awareness, attitudes, professional experiences, educational exposure, and educational needs regarding LGBTQ+ healthcare, and to explore whether responses to selected items on difficulty providing care and participation in LGBTQ+ advocacy differed by demographic and professional characteristics.</p><p><strong>Methods: </strong>We conducted a quantitative cross-sectional study in Thessaloniki, Greece, between October 2023 and January 2024, involving 305 CPs (59.8% of the 510 pharmacists invited). Data were collected using a 35-item questionnaire covering self-reported knowledge and awareness, educational exposure and preparedness, ethical perceptions, professional experiences and behaviours, advocacy and awareness activities, and demographic and professional characteristics. Descriptive statistics and unadjusted subgroup comparisons were performed using SPSS, applying independent-samples t-tests and one-way ANOVA, as appropriate. Statistical significance was set at <i>p</i> < 0.05.</p><p><strong>Results: </strong>Participants reported generally positive attitudes toward LGBTQ+ patients; however, only 43.0% reported adequate training in LGBTQ+-specific healthcare needs. Participation in LGBTQ+ advocacy and awareness activities differed significantly across age groups (F(3,301) = 7.058, <i>p</i> < 0.001), with younger pharmacists reporting higher engagement. Advocacy participation also differed significantly across professional-experience groups (F(2,302) = 9.146, <i>p</i> < 0.001), with pharmacists with fewer than 10 years of experience reporting greater involvement than those with >10 years. Female pharmacists reported significantly higher advocacy engagement than males (t(303) = -4.089, <i>p</i> < 0.001). No robust statistically significant group differences were identified in self-reported difficulties in providing care across the demographic and professional characteristics examined.</p><p><strong>Conclusions: </strong>While attitudes are positive, important educational gaps persist. This highlights the need for structured LGBTQ+ inclusive undergraduate pharmacy curricula and continuing professional development to ensure competent, respectful, and inclusive care for LGBTQ+ individuals.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2753953"},"PeriodicalIF":2.6,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13757916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of pharmacists' involvement in pharmacogenomics implementation on patient outcomes: a scoping review. 药师参与药物基因组学实施对患者预后的影响:范围综述。
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-11-03 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2746884
Nadia Al Mazrouei, Khalid Awad Al-Kubaisi, Karem H Alzoubi, Ahmed Alhusban, Richard Mottershead, Moh'D Ahmad Shara, Manal Mohammed Al Sharawy, Margaret Stevenson
{"title":"Effects of pharmacists' involvement in pharmacogenomics implementation on patient outcomes: a scoping review.","authors":"Nadia Al Mazrouei, Khalid Awad Al-Kubaisi, Karem H Alzoubi, Ahmed Alhusban, Richard Mottershead, Moh'D Ahmad Shara, Manal Mohammed Al Sharawy, Margaret Stevenson","doi":"10.1080/20523211.2026.2746884","DOIUrl":"https://doi.org/10.1080/20523211.2026.2746884","url":null,"abstract":"<p><strong>Background: </strong>Pharmacogenomics holds promise for personalised medicine, but its implementation requires effective integration into clinical workflows. Pharmacists, with their medication expertise, are positioned to play a key role in implementing these services. However, a comprehensive synthesis of evidence regarding pharmacists' roles in pharmacogenomic implementation has been lacking.</p><p><strong>Methods: </strong>A scoping review was conducted following a pre-registered protocol and PRISMA-ScR guidance. PubMed/MEDLINE, Scopus, Cochrane Library, CINAHL, and PsycINFO were searched from January 2015 to September 2026, supplemented by grey literature and reference screening. Studies examining pharmacist involvement in clinical PGx implementation were eligible. Data were extracted, critically appraised using design-specific tools, and synthesised thematically.</p><p><strong>Results: </strong>From an initial yield of 870 records identified through database and grey literature searching, studies were screened, and eligible evidence was synthesised in this scoping review. Included literature comprised cross-sectional (n = 2), quasi-experimental (n = 1), case series (n = 5), qualitative (n = 1), mixed-methods (n = 1), descriptive implementation (n = 3), and an AI-based clinical decision-support evaluation (n = 1). Overall methodological quality was moderate to low, reflecting predominantly observational and implementation-oriented designs. Thematic synthesis identified key domains: pharmacist roles in PGx workflow integration, result interpretation, clinical decision support use, interprofessional collaboration, patient education, medication optimization, implementation leadership, and system-level barriers.</p><p><strong>Conclusion: </strong>Pharmacists are central to successful PGx implementation across diverse healthcare settings. Although evidence supports improvements in implementation processes and prescribing decisions, robust evidence demonstrating long-term clinical and economic benefits remains limited. Future research should prioritise rigorous outcome-focused evaluations to support sustainable integration of pharmacist-led PGx services.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2746884"},"PeriodicalIF":2.6,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13757929/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementing the national action plans on antimicrobial resistance in Jordan: document analysis and policymakers' perspectives. 在约旦实施抗微生物药物耐药性国家行动计划:文件分析和决策者的观点。
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-10-20 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2735525
Raja'a Al-Qudah, Sarah C Willis, Ellen I Schafheutle
{"title":"Implementing the national action plans on antimicrobial resistance in Jordan: document analysis and policymakers' perspectives.","authors":"Raja'a Al-Qudah, Sarah C Willis, Ellen I Schafheutle","doi":"10.1080/20523211.2026.2735525","DOIUrl":"https://doi.org/10.1080/20523211.2026.2735525","url":null,"abstract":"<p><strong>Background: </strong>The World Health Organization (WHO) developed the Global Action Plan (GAP) on Antimicrobial Resistance (AMR) in response to its growing threat to human, animal, and agricultural health. Countries worldwide were encouraged to implement National Action Plans (NAPs) to combat AMR. However, low- and middle-income countries (LMICs) face difficulties in implementing NAPs. This study aimed to investigate the implementation of AMR policy in Jordan and assess progress under its NAP.</p><p><strong>Methods: </strong>Using the Implementation Research (IR) framework, this study involved documentary analysis of five policy documents and 17 semi-structured interviews with policymakers. Guided by the IR framework's three phases (proof of concept, proof of implementation, informing scale-up), document analysis was conducted deductively, while the interviews were analysed inductively and deductively using thematic analysis supported by NVivo.</p><p><strong>Results: </strong>Three key themes emerged: implementation challenges, strategy design, and outcome evaluation. Problem identification and context analysis showed that while Jordan's NAP aligns with the WHO's GAP, poor intersectoral coordination, limited stakeholder engagement, and weak enforcement hinder implementation. Participants noted unclear roles for policymakers, creating accountability gaps and inefficiencies. Implementation strategies showed that AMR interventions focus on hospitals, with little attention to other sectors (community pharmacy and primary care). Differences between public and private hospitals led to inconsistent enforcement, while unenforced community pharmacy regulation allowed for unregulated access to antibiotics. Monitoring and evaluating AMR interventions remain key gaps, with a lack of standardised frameworks, fragmented surveillance data, and insufficient monitoring capacity.</p><p><strong>Conclusion: </strong>Although aligned with WHO's GAP, AMR policy implementation in Jordan is hindered by systemic barriers: weak enforcement, limited stakeholder engagement, and fragmented accountability. A focus on hospitals left other settings with limited action or reinforcement. The findings highlighted the need for cross-sector coordination and robust monitoring. While context-specific, these insights may inform AMR governance in comparable settings.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2735525"},"PeriodicalIF":2.6,"publicationDate":"2026-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13686185/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149245068","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of affordability and availability of antidepressants in China from 2019 to 2022: evidence from national procurement database. 2019年至2022年中国抗抑郁药的可负担性和可获得性比较:来自国家采购数据库的证据
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-10-14 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2719527
Xiao Han, Qingyuan Xue, Zhao Yang, Jifang Zhou, Bin Jiang
{"title":"Comparison of affordability and availability of antidepressants in China from 2019 to 2022: evidence from national procurement database.","authors":"Xiao Han, Qingyuan Xue, Zhao Yang, Jifang Zhou, Bin Jiang","doi":"10.1080/20523211.2026.2719527","DOIUrl":"10.1080/20523211.2026.2719527","url":null,"abstract":"<p><strong>Background: </strong>Depression is a widespread mental disorder imposing significant societal burdens. The COVID-19 pandemic exacerbated its prevalence, emphasizing the need for improved access to affordable and effective treatments. This study aims to examine the trends of antidepressant availability and affordability in China from 2019 to 2022 and the role of the National Volume-Based Procurement (NVBP) policy.</p><p><strong>Methods: </strong>Using nationwide daily procurement data of 19 antidepressants encompassing all medical facilities in China from 2019 to 2022, this study adapted the World Health Organization/Health Action International (WHO/HAI) methodology. Availability was defined as the percentage of health facilities procuring specific antidepressant during the year. Affordability was expressed as the number of days at provincial minimum wage to pay for a one-month course of treatment. Temporal variations were described and explored using fractional logit regression, stratified by originator, NVBP involvement, clinical preference, hospital features, and regions.</p><p><strong>Results: </strong>Affordability improved steadily between 2019 and 2022 across most antidepressant groups. The largest improvement occurred among first-line NVBP antidepressants, where the monthly expenditure declined by 0.022-day minimum wage annually. In contrast, affordability changed little for first-line non-NVBP medicines (0.015-day decrease per year) and second-line non-NVBP medicines (0.004-day decrease per year). Availability of originator brands declined annually by 0.8 percentage points, while lowest-priced generics increased by 1.1 percentage points. The largest decline occurred in tertiary private facilities, where availability fell by 3.7 percentage points annually. Improvements in availability were mainly observed in secondary and tertiary public facilities, particularly in the East and Northeast regions. Overall, NVBP first-line medicines had 15.5 percentage points higher availability and greater affordability of 0.167-day minimum wage than other antidepressants.</p><p><strong>Conclusion: </strong>The study highlights the positive influence of the NVBP policy on antidepressant affordability and availability. Regional gaps and facility-specific disparities, though narrowed, still call for policy response.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2719527"},"PeriodicalIF":2.6,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670268/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149216139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and psychometric evaluation of the knowledge, attitudes, and practices toward complementary and alternative medicine in stroke. 卒中补充和替代医学的知识、态度和实践的发展和心理测量学评估。
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-10-02 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2739009
Lee Jia Jia, Stephanie Cheah Ee Lin, Kasmithra K Batu Ganesan, Devonnysa Saliboh, Jamuna Rani Appalasamy, Ng Khuen Yen, Jasmine Chia Siew Min, Yee Siew Mei, Amutha Selvaraj, Ali Haider Mohammed
{"title":"Development and psychometric evaluation of the knowledge, attitudes, and practices toward complementary and alternative medicine in stroke.","authors":"Lee Jia Jia, Stephanie Cheah Ee Lin, Kasmithra K Batu Ganesan, Devonnysa Saliboh, Jamuna Rani Appalasamy, Ng Khuen Yen, Jasmine Chia Siew Min, Yee Siew Mei, Amutha Selvaraj, Ali Haider Mohammed","doi":"10.1080/20523211.2026.2739009","DOIUrl":"10.1080/20523211.2026.2739009","url":null,"abstract":"<p><strong>Background: </strong>Stroke is a major public health concern and leading cause of long-term disability. Complementary and alternative medicine (CAM) is increasingly used in stroke management, yet public knowledge, attitudes, and practices (KAP) regarding its use remain poorly understood. Misconceptions or lack of awareness may lead to unsafe practices and delays in seeking medical care.</p><p><strong>Objective: </strong>The study aimed to develop the Knowledge, Attitude and Practice toward Complementary and Alternative Medicine use in Stroke Management (KAP-CAM-Stroke) questionnaire and conduct an initial psychometric evaluation.</p><p><strong>Methods: </strong>This multi-phase instrument-development study comprised Phase I, which included item generation, content validation using a two-round Delphi technique, face validity, and pilot testing, and Phase II, which used a cross-sectional survey to conduct an initial psychometric evaluation in 136 members of the Malaysian public. IRT was applied to the knowledge domain, whereas EFA was used for the attitude and practice domains.</p><p><strong>Results: </strong>The final questionnaire comprised 58 items across four sections: sociodemographic (16 items), knowledge (10 items), attitude (10 items), and practice (22 items). Content validity was supported by S-CVI/Ave values of at least 0.90 after Delphi Round 2. IRT identified variable item performance in the knowledge domain, including an unstable extreme discrimination estimate for item K4. EFA identified a four-factor attitude structure explaining 63.84% of the variance (Cronbach's alpha = 0.655) and a six-factor practice structure explaining 74.94% (Cronbach's alpha = 0.860). These findings provide preliminary evidence of content and structural validity; internal consistency met the prespecified threshold for the knowledge and practice domains but not for the attitude domain.</p><p><strong>Conclusion: </strong>The KAP-CAM-Stroke questionnaire provides preliminary psychometric evidence for assessing public knowledge, attitudes, and practices regarding CAM use in stroke management. Further evaluation in larger and more diverse samples, including test-retest reliability and confirmatory factor analysis, is required before the instrument can be considered fully validated.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2739009"},"PeriodicalIF":2.6,"publicationDate":"2026-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13644441/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149137345","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characteristics, preventability, management, and predictors of adverse drug reaction-related hospital admissions: a cross-sectional study in a Thai tertiary care hospital. 药物不良反应相关住院的特点、可预防性、管理和预测因素:泰国三级医院的横断面研究
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-10-01 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2734106
Warisara Jiamsathit, Thanyamai Sapsinpan, Phrompassorn Khumwatrungruang, Anthony R Cox, Narumol Jarernsiripornkul
{"title":"Characteristics, preventability, management, and predictors of adverse drug reaction-related hospital admissions: a cross-sectional study in a Thai tertiary care hospital.","authors":"Warisara Jiamsathit, Thanyamai Sapsinpan, Phrompassorn Khumwatrungruang, Anthony R Cox, Narumol Jarernsiripornkul","doi":"10.1080/20523211.2026.2734106","DOIUrl":"https://doi.org/10.1080/20523211.2026.2734106","url":null,"abstract":"<p><strong>Background: </strong>Adverse drug reaction (ADR)-related hospital admissions may be fatal and increase substantial healthcare costs, but several ADRs are preventable. However, studies on preventable ADRs in Thailand remain limited, particularly with respect to their management and prevention. Aim To determine the frequency, characteristics, and preventability of ADR-related hospital admission, and to evaluate the management, prevention strategies, and associated factors.</p><p><strong>Methods: </strong>A cross-sectional study was conducted among patients admitted to a tertiary care teaching hospital. Data were extracted from the hospital's medical record database for a 9-month period. ADR-related hospital admissions were identified using the International Statistical Classification of Diseases and Related Health Problems, 10<sup>th</sup> Revision (ICD-10).</p><p><strong>Results: </strong>During the study period, 29,927 patients were admitted to the hospital. Of these, 730 admissions were identified as ADR-related based on ICD-10 codes, and 200 patients were included using purposive sampling. The most frequently reported ADRs involved cardiovascular disorders (50.5%), and nervous system disorders (17.0%). The most common suspected drugs were warfarin (38.0%) and paracetamol (5.0%). Approximately 67.1% of ADRs were classified as probable or definite, and 66.0% were considered preventable. The primary management strategy was discontinuation of the suspected drug (82.5%), while discharge counselling was the most commonly employed preventive measure (56.0%). Inappropriate dosage was independently associated with the preventability of ADR-related hospital admissions (OR 0.007; 95% CI 0.001-0.074; <i>p</i> < 0.001), and age groups of 36-65 years and more than 65 years were independently associated with documented ADR-related hospital admissions (OR 7.688; 95% CI 1.533-38.548; <i>p</i> = 0.013 and OR 9.441; 95% CI 1.668-53.422; <i>p</i> = 0.011, respectively).</p><p><strong>Conclusions: </strong>Warfarin was the most frequently implicated drug in ADR-related hospital admissions. Inappropriate dosing was significantly associated with preventable ADR-related hospitalisations. Implementing targeted strategies, such as dose optimisation and appropriate clinical monitoring, may enhance medication safety and reduce preventable ADRs.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2734106"},"PeriodicalIF":2.6,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13637779/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111171","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rethinking assessment for practice readiness: policy implications of the OSCE-practice mismatch in Malaysia. 反思实践准备评估:欧安组织-马来西亚实践不匹配的政策含义。
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-09-30 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2735132
Athirah Bakhtiar, Angelina Lim, Li Ling Yeap, Daniel Malone, Han Yin Lim, Sunanthiny Krishnan
{"title":"Rethinking assessment for practice readiness: policy implications of the OSCE-practice mismatch in Malaysia.","authors":"Athirah Bakhtiar, Angelina Lim, Li Ling Yeap, Daniel Malone, Han Yin Lim, Sunanthiny Krishnan","doi":"10.1080/20523211.2026.2735132","DOIUrl":"https://doi.org/10.1080/20523211.2026.2735132","url":null,"abstract":"<p><strong>Background: </strong>Experiential learning is central to pharmacy education, yet the translation of clinical skills from simulated examinations to actual practice remains under-researched. This study utilised mystery shopping to evaluate how well clinical competencies transfer when students move from university Objective Structured Clinical Examinations (OSCEs) to independent community pharmacy placements, shedding light on systemic barriers to clinical care integration.</p><p><strong>Methods: </strong>Using a sequential explanatory mixed-methods design, 57 third-year undergraduate pharmacy students were covertly evaluated during their placements by mystery shoppers reenacting clinical scenarios identical to those used in the primary-care component of their university OSCEs. Scores were compared using Wilcoxon signed-rank tests and Spearman's correlation. Additionally, semi-structured interviews explored students' perspectives on the performance gap and the systemic obstacles that prevent successful skill transfer.</p><p><strong>Results: </strong>Real-world performance was markedly lower than examination scores, with mystery shopping scores dropping to a median of 0% versus 91.67% in the OSCE (<i>p</i> < 0.001). No significant correlation existed between simulated success and independent execution (r<sub>s</sub> = 0.14, <i>p</i> = 0.2934). Qualitative analysis identified three main drivers for this mismatch: the disconnect between structured examinations and fluid retail practice; environmental distractions; and restrictive public expectations that actively discouraged thorough clinical counselling.</p><p><strong>Conclusion: </strong>Simulated clinical competence does not reliably translate to independent practice. This performance drop illustrates how national policy and retail realities constrain a student's actual clinical output. Integrating independent workplace assessments, such as mystery shopping, may provide a more direct, unsupervised measure of readiness. Bridging this gap will likely require coordinated efforts among academic institutions, practising pharmacists, and regulatory bodies. These findings may offer preliminary insights relevant to other developing health systems navigating similar transitions in clinical pharmacy practice, pending further research across diverse settings.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2735132"},"PeriodicalIF":2.6,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13629800/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111302","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pharmacy professionals' knowledge, attitudes, and behaviours regarding antibiotic use and antimicrobial resistance in Oman. 阿曼药学专业人员关于抗生素使用和抗菌素耐药性的知识、态度和行为。
IF 2.6
Journal of Pharmaceutical Policy and Practice Pub Date : 2026-09-30 eCollection Date: 2026-01-01 DOI: 10.1080/20523211.2026.2737505
Zainab Said Al-Hashimy, Barbara R Conway, Marwa Al Qasmi, Huda Al Harthi, Rashid Al Harthi, Feras Darwish Elhajji, Mamoon A Aldeyab
{"title":"Pharmacy professionals' knowledge, attitudes, and behaviours regarding antibiotic use and antimicrobial resistance in Oman.","authors":"Zainab Said Al-Hashimy, Barbara R Conway, Marwa Al Qasmi, Huda Al Harthi, Rashid Al Harthi, Feras Darwish Elhajji, Mamoon A Aldeyab","doi":"10.1080/20523211.2026.2737505","DOIUrl":"https://doi.org/10.1080/20523211.2026.2737505","url":null,"abstract":"<p><strong>Background: </strong>This study evaluated pharmacy professionals' knowledge, attitudes, and behaviours regarding antibiotic use and antimicrobial resistance (AMR) in Oman.</p><p><strong>Methods: </strong>A cross-sectional, questionnaire-based survey was conducted among 411 pharmacy professionals in Ministry of Health (MOH) institutions from January to June 2023. This questionnaire is based on instruments developed by the European Centre for Disease Prevention and Control and assesses knowledge, opportunities, behaviours, and awareness of national initiatives.</p><p><strong>Results: </strong>A total of 411 pharmacy professionals participated in the study. Overall, participants demonstrated knowledge of AMR, with an understanding of antibiotic effectiveness against viruses (89.3%) and inappropriate use (96.4%), but important gaps in knowledge of resistance transmission (44.8%) and antibiotic use for growth promotion in farm animals (31.4%). Higher median knowledge scores were observed among senior specialist pharmacists ( <math><mi>p</mi> <mo><</mo> <mn>0.001</mn></math> ), while respondents aged 36-45 years and those with 16-20 years of practice achieved the highest proportions of full knowledge scores ( <math><mi>p</mi> <mo><</mo> <mn>0.001</mn></math> ). Although 91% of respondents reported confidence in their understanding of AMR, specific knowledge gaps were identified: 56.2% were unsure whether antibiotic use for growth promotion in farm animals was legal in Oman, and 36% were unaware of or unsure about Oman's National Action Plan. Most respondents reported having opportunities to provide patient counselling (82%) and access to guidelines (63%), while 59.9% reported frequent antibiotic dispensing in practice. Importantly, among the 217 respondents who reported that the information changed their views, 208 (95.9%) participants indicated that this knowledge influenced their dispensing practices.</p><p><strong>Conclusions: </strong>Pharmacy professionals in Oman demonstrated awareness and positive perceptions regarding antibiotic use and antimicrobial resistance, although gaps remained in awareness and understanding of One Health principles, national initiatives, and the translation of knowledge into dispensing practice. Strengthening targeted education, guideline access, and pharmacist involvement in antimicrobial stewardship may improve appropriate antibiotic use and support AMR control.</p>","PeriodicalId":16740,"journal":{"name":"Journal of Pharmaceutical Policy and Practice","volume":"19 1","pages":"2737505"},"PeriodicalIF":2.6,"publicationDate":"2026-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13629792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149111199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书